Advisor and Board Member @ (October 2024 - Present)
CEO | Brought Affimed from Early Stage Pre-Clinical Engineering to Late-Stage Clinical Development @ (January 2011 - January 2024)
Chief Executive Officer (CEO) | Secured €30M Investment to Form and Launch Spin-Off from Jerini AG @ Jenowis AG (January 2009 - January 2010)
Chief Commercial Officer | Introduced and Commercialized Firazyr | Key Player in Shire’s M and A Process @ (January 2002 - January 2009)
General Manager and Vice President of Molecular Medicine Division @ Carl-Zeiss (January 2000 - January 2002)
Vice President, Licensing and Business Development | Director, Business Development | Biotech IPO @ (January 1997 - January 2000)
Scientist | Management of Discovery Unit @ (January 1993 - January 1997)
Adi Hoess Education
Harvard Medical School
Post Doctorate
University of Munich
Doctor of Philosophy - PhD (Chemistry, Biochemistry)
Technical University of Munich
Doctorate of Medicine
Adi Hoess Skills
Training
Art Direction
Photoshop
Adobe Creative Suite
Strategic Planning
Social Media
Sales
Project Management
Marketing
Business Development
Leadership
Business Planning
Entrepreneurship
Copywriting
Creative Direction
Business Strategy
User Experience
Corporate Branding
Adi Hoess Summary
Adi Hoess, based in Germany, is currently a Chief Executive Officer at Vianautis. Adi Hoess brings experience from previous roles at JJP Biologics, ALKemist Bio, Affimed AG and Jenowis AG. Adi Hoess holds a Post Doctorate @ Harvard Medical School. With a robust skill set that includes Training, Art Direction, Photoshop, Adobe Creative Suite, Strategic Planning and more. Adi Hoess has 1 emails on RocketReach.
Looking for a different Adi Hoess?
Find contact details for 700 million professionals.